These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10715276)

  • 1. Qualification of the concepts of unqualified success and unmitigated failure.
    Kessler KM
    Circulation; 2000 Mar; 101(10):E98; author reply E99. PubMed ID: 10715276
    [No Abstract]   [Full Text] [Related]  

  • 2. Qualification of the concepts of unqualified success and unmitigated failure.
    Francis DP; Davies LC; Coats AJ
    Circulation; 2000 Mar; 101(10):E99. PubMed ID: 10715277
    [No Abstract]   [Full Text] [Related]  

  • 3. Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine.
    Mancini GB; Schulzer M
    Circulation; 1999 Jan; 99(3):377-83. PubMed ID: 9918524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events.
    Schulzer M; Mancini GB
    Int J Epidemiol; 1996 Aug; 25(4):704-12. PubMed ID: 8921446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Khan OA; Tselis A; Boster A
    Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
    [No Abstract]   [Full Text] [Related]  

  • 6. The ISAT. Again..
    Figueiredo EG
    World Neurosurg; 2010 Jun; 73(6):601-3. PubMed ID: 20934133
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on the risk and benefit of aspirin therapy: an application of the concepts of unqualified success and unmitigated failure.
    Cragg JJ; Schulzer M; Mancini GB
    J Clin Epidemiol; 2013 Jul; 66(7):803-5. PubMed ID: 23523548
    [No Abstract]   [Full Text] [Related]  

  • 9. Composite outcomes in clinical trials: what are they and when should they be used?
    Heddle NM; Cook RJ
    Transfusion; 2011 Jan; 51(1):11-3. PubMed ID: 21219322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor response evaluation].
    Watanabe H; Higashino T; Ohno Y; Takenaka D; Sugimura K
    Nihon Rinsho; 2002 May; 60 Suppl 5():322-8. PubMed ID: 12101681
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical significance of new therapies for the management of periodontal disease.
    Van Dyke TE
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):191-6. PubMed ID: 16248275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardizing end points in perioperative trials: towards a core and extended outcome set.
    Myles PS; Grocott MP; Boney O; Moonesinghe SR;
    Br J Anaesth; 2016 May; 116(5):586-9. PubMed ID: 27106961
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of the Task Force Report on PRO data collection in clinical trials using mixed modes.
    McLeod L
    Value Health; 2014 Jul; 17(5):491-2. PubMed ID: 25128040
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients are urged to boycott trials that do not guarantee publication.
    Kmietowicz Z
    BMJ; 2013 Jan; 346():f106. PubMed ID: 23299902
    [No Abstract]   [Full Text] [Related]  

  • 15. Reliability of the modified Rankin Scale: a systematic review.
    Quinn TJ; Dawson J; Walters MR; Lees KR
    Stroke; 2009 Oct; 40(10):3393-5. PubMed ID: 19679846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting and interpreting results of systematic reviews.
    Harvey L; Wyndaele JJ
    Spinal Cord; 2009 Nov; 47(11):777. PubMed ID: 19890366
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of occipital nerve stimulation in studies of chronic migraine and broader implications of social media in clinical trials.
    Goadsby PJ
    Cephalalgia; 2013 Feb; 33(3):214-5. PubMed ID: 23212293
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of generalisability in trials of health interventions: suggested framework and systematic review.
    Bonell C; Oakley A; Hargreaves J; Strange V; Rees R
    BMJ; 2006 Aug; 333(7563):346-9. PubMed ID: 16902217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistics and the relationship of clinical research to clinical practice.
    Khuder SA; Kahaleh B
    J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
    [No Abstract]   [Full Text] [Related]  

  • 20. [Validity of clinical trials: are there differences between conventional and complementary alternative medicine?].
    Porzsolt F; Linde K; Witt C; Mühlhauser I; Runkel F; Habs M
    Dtsch Med Wochenschr; 2010 Jul; 135(30):1503-6. PubMed ID: 20648411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.